Medication info
Kacey Family 10 Milligrams (Dapagliflozin Propanediol Hydrate)

Kacey Family 10 Milligrams (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
KS Pharmaceutical Co., Ltd.
Appearance
Yellow, biconvex, diamond-shaped film-coated tablet
Packaging
PTP packaging - 28 tablets/box [(7 tablets/PTP × 4)]
Approval status
Active

MFDS item code 202300403 · Approved 2023.01.31 · Insurance code 059001140

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
Under 18 years of age: The efficacy and safety of dapagliflozin have not been established. There are no relevant data.

Ingredients

Manufacturer
KS Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

  • Difficulty in controlling blood sugar levels in patients with type 2 diabetes
  • poor blood sugar control
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used alongside dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It can be used as monotherapy or in combination with other medications as needed. It should particularly be used under the guidance of a healthcare professional for patients with cardiovascular disease or risk factors among those whose blood sugar levels are not adequately controlled. This medication helps improve blood sugar control and manage the risk of cardiovascular events.

How to take

Adult dose

Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

Under 18 years of age: The efficacy and safety of dapagliflozin have not been established. There are no relevant data.

Precautions

This medication should not be administered to certain patients. Individuals allergic to the active ingredient or excipients, those with type 1 diabetes, or those with diabetic ketoacidosis should not use it. Additionally, due to the presence of anhydrous lactose, individuals with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should also avoid it. Patients undergoing dialysis should not take this medication. Patients with reduced fluid volume or kidney function issues should use this medication with caution. There is a risk of low blood pressure or rapid deterioration of kidney function; thus, fluid volume and kidney function should be properly assessed before administration. This is particularly important for elderly patients or those taking certain diuretics, who should be closely monitored for symptoms of low blood pressure and changes in kidney function during treatment. In patients with moderate to severe kidney function impairment, blood sugar control efficacy may decrease. This medication may cause side effects such as genital infections, urinary tract infections, hypoglycemia, reduction in fluid volume, and diabetic ketoacidosis. Genital infections are particularly more common in women, and appropriate treatment should be sought if symptoms occur. Hypoglycemia may occur more frequently when used in combination with medications like insulin or sulfonylureas, so dosage adjustments may be necessary. Due to reduced fluid volume, symptoms of dehydration or low blood pressure may arise, which should be monitored. Diabetic ketoacidosis can occur even when blood sugar levels are not elevated, so immediate testing and treatment are necessary if related symptoms appear. In patients with compromised liver function or elderly patients, caution is advised when using this medication, and regular testing is necessary if there is a risk of reduced fluid volume. During the use of this medication, urine tests may show positive results for glucose, which should be noted. When taken with insulin or sulfonylureas, there is a risk of hypoglycemia, so dosage adjustments for these medications may be necessary. Additionally, the use of this medication in combination with certain diuretics may increase the risk of dehydration and low blood pressure, necessitating caution. Pregnant women are advised not to use this medication, and it should be discontinued immediately if pregnancy is confirmed. Nursing mothers should also avoid this medication as safety has not been established. The safety and efficacy of this medication have not been established in pediatric patients, so its use is not recommended. There is no specific antidote for overdose; appropriate supportive treatment should be provided based on the patient’s condition. This medication does not significantly affect the ability to drive or operate machinery; however, caution is required when taken with insulin or sulfonylureas due to the risk of hypoglycemia. Lastly, this medication should be stored out of reach of children, kept in its original container, and container changes should be avoided to maintain product quality.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased renal creatinine clearance in the early stages of treatment, dyslipidemia, increased serum creatinine in the early stages of treatment, elevated blood urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, biliary stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, sensory abnormalities, cerebral infarction, nerve compression, sensory loss, headache, nasopharyngitis, upper respiratory tract infection, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularity, pruritus, urticaria, cold sweats, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy and safety of the medication.

Appearance and packaging

Appearance

Yellow, biconvex, diamond-shaped film-coated tablet

Package unit

PTP packaging - 28 tablets/box [(7 tablets/PTP × 4)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.